retinoblastoma gene product
Recently Published Documents


TOTAL DOCUMENTS

124
(FIVE YEARS 0)

H-INDEX

44
(FIVE YEARS 0)

2008 ◽  
Vol 14 (6) ◽  
pp. 295-301 ◽  
Author(s):  
Nobuyoshi Kawakita ◽  
Shuichi Seki ◽  
Hiroki Sakaguchi ◽  
Atsushi Yanai ◽  
Kazuki Nakatani ◽  
...  

2004 ◽  
Vol 82 (5) ◽  
pp. 583-588 ◽  
Author(s):  
Naokatu Arakaki ◽  
Ayako Toyofuku ◽  
Yuka Emoto ◽  
Tomoko Nagao ◽  
Yoshinori Kuramoto ◽  
...  

Dietary flavonoids have demonstrated anti-carcinogenic activity in several animal models, but their mechanisms of action have not yet been clearly established. Here, we show that flavone, a parent compound of flavonoids, inhibits the proliferation, migration, and capillary tube formation of human umbilical vein endothelial cells (HUVECs). Flow cytometric analysis showed that flavone arrests the cell cycle progression at G1 phase in HUVECs. We observed the down-regulation of the hyperphosphorylated form of retinoblastoma gene product and cyclin-dependent kinases 2 and 4 in flavone-treated cells, but it had no affect on the expression of p53 and cyclin-dependent kinase inhibitors p21CIP/Waf1 and p27Kip. Flavone almost completely inhibited the activation of extracellular signal regulated kinase 1. The present results suggest that the flavone moiety of flavonoids is required for anti-proliferative activity of flavonoids and that anti-carcinogenic action of flavonoids in vivo was mediated, at least in part, by inhibiting angiogenesis.Key words: flavone, angiogenesis, human umbilical vein endothelial cells (HUVECs), cell cycle, retinoblastoma gene product (Rb), ERK.


2002 ◽  
Vol 35 (6) ◽  
pp. 1233-1241
Author(s):  
Nayan Sivamurthy ◽  
David H. Stone ◽  
Frank W. LoGerfo ◽  
William C. Quist

Sign in / Sign up

Export Citation Format

Share Document